LAMB1

LAMB1 encodes the laminin beta-1 chain, a large multidomain extracellular matrix glycoprotein built from cysteine-rich type A repeats, type B repeats, and globular and helical regions that contribute to basement membrane assembly (PMID:3611077). Its transcription is induced by retinoic acid through a cAMP/PKA-dependent enhancer that activates a C2-binding protein (PMID:9419418) and is driven in cancer by an ERK/c-Jun axis in which c-Jun binds the LAMB1 promoter directly (PMID:33435161), while its mRNA is stabilized post-transcriptionally by DDX24 binding a defined site in cooperation with nucleolin (PMID:35763670). As a secreted matrix protein, LAMB1 functions as an extracellular guidance and mechanotransduction cue: vascular LAMB1 forms a haptotactic gradient sensed by integrin alpha-6 to activate Rac1 and direct microglial precursor migration into the retina (PMID:41206867), and it binds focal adhesion kinase to convert substrate stiffness into MEK1/2 signaling (PMID:36519511). In disease and tumor contexts LAMB1 acts upstream of multiple intracellular cascades, promoting Wnt/β-catenin/VEGFA-driven angiogenesis (PMID:40221061) and NF-κB/HK2-driven glycolysis in glioma (PMID:39920513). A dominant missense mutation in mouse Lamb1 causes a dystonia-like movement disorder with abnormal cerebellar output (PMID:26705335), and human LAMB1 truncating variants cause leukoencephalopathy, acting either through cytosolic trapping of truncated protein (PMID:34606115) or, for late truncations, through secretion of a monomeric truncated form consistent with a gain-of-function mechanism (PMID:40237576).

1. 1987 High

   Established the molecular identity of LAMB1 by defining its multidomain architecture and chromosomal location, providing the foundation for all subsequent functional work.

   Evidence cDNA cloning, sequence analysis, and chromosomal mapping by somatic cell hybrid and in situ hybridization

   PMID:3611077

   Open questions at the time

   • No functional assignment to individual domains
   • No structural model of assembled laminin
2. 1997 Medium

   Resolved how LAMB1 transcription is induced developmentally, showing retinoic acid acts through a cAMP/PKA-dependent enhancer requiring a specific C2-binding factor.

   Evidence Dominant-negative PKA transfection, CAT reporter, DNase I hypersensitivity, and EMSA in F9 teratocarcinoma cells

   PMID:9419418

   Open questions at the time

   • Identity of the C2-binding protein not determined
   • Generalizability beyond F9 cells unclear
3. 1997 Medium

   Mapped the cis-regulatory elements controlling tissue-specific LAMB1 expression, separating a minimal proximal promoter from distal elements needed in reproductive epithelia.

   Evidence Transgenic mouse promoter-lacZ reporter lines with two promoter fragments

   PMID:9447707

   Open questions at the time

   • Trans-acting factors at distal elements not identified
   • No link to protein function
4. 2015 High

   Demonstrated a CNS role for LAMB1 beyond basement membranes, with a dominant missense mutation causing dystonia-like movement through abnormal cerebellar circuit output.

   Evidence Exome sequencing plus in vivo awake cerebellar electrophysiology and EMG in mutant mice

   PMID:26705335

   Open questions at the time

   • Molecular consequence of the missense change on laminin assembly unknown
   • Synaptic mechanism not directly defined
5. 2021 Medium

   Defined the cellular pathology of recessive LAMB1 leukoencephalopathy, showing truncated protein escaping NMD is trapped in the cytosol rather than secreted.

   Evidence Western blotting with N- and C-terminal antibodies in patient fibroblasts plus collapsing variant analysis

   PMID:34606115

   Open questions at the time

   • Mechanism linking cytosolic trapping to neuropathology unresolved
   • Single-lab patient cell analysis
6. 2021 Medium

   Placed LAMB1 downstream of oncogenic ERK signaling by showing c-Jun directly transactivates its promoter to drive gastric cancer growth.

   Evidence Overexpression/knockdown, ERK inhibitor, ChIP for c-Jun, and proliferation/invasion assays in gastric cancer cells

   PMID:33435161

   Open questions at the time

   • Downstream effectors of LAMB1 in gastric cancer not defined
   • Single-lab study
7. 2022 High

   Identified a post-transcriptional control mechanism, showing DDX24 binds a defined LAMB1 mRNA site and stabilizes it via nucleolin to promote HCC progression.

   Evidence RIP mapping, mRNA stability assay, DDX24-nucleolin Co-IP, and in vitro/in vivo tumor models

   PMID:35763670

   Open questions at the time

   • Whether stabilization operates in non-tumor tissues unknown
   • Receptor/effector downstream of elevated LAMB1 protein not addressed
8. 2023 Medium

   Established LAMB1 as a mechanotransducer, showing it binds FAK to convert substrate stiffness into MEK1/2 signaling during dentinogenesis.

   Evidence Co-immunoprecipitation, stiffness-variable PDMS substrates, and pathway Western blotting in odontoblast-like cells

   PMID:36519511

   Open questions at the time

   • Direct vs indirect LAMB1-FAK interaction not distinguished
   • Single-lab, single cell type
9. 2025 High

   Defined a conserved haptotactic guidance function, showing vascular LAMB1 engages integrin alpha-6 to activate Rac1 and direct microglial precursor migration into the retina.

   Evidence Zebrafish live imaging, endothelial-specific conditional KO in mice, F-actin polarization and Rac1 activity assays

   PMID:41206867

   Open questions at the time

   • Structural basis of the LAMB1-Itga6 gradient not resolved
   • Other receptors contributing to migration not excluded
10. 2025 Medium

    Distinguished the disease mechanism of late LAMB1 truncations, showing they uniquely secrete as monomers consistent with dominant gain-of-function, and confirmed a conserved BBB role.

    Evidence Drosophila LanB1 RNAi and rescue, immunofluorescence, and HEK293T variant secretion assays

    PMID:40237576

    Open questions at the time

    • How secreted monomeric truncated protein produces toxicity unknown
    • Human in vivo validation lacking
11. 2025 Medium

    Placed LAMB1 upstream of pro-angiogenic Wnt signaling, showing knockdown reduces Wnt/β-catenin/VEGFA and impairs endothelial tube formation, rescuable by a Wnt agonist.

    Evidence siRNA knockdown in HUVECs, Wnt agonist rescue, tube formation and migration assays, scRNA-seq pseudotime

    PMID:40221061

    Open questions at the time

    • Receptor coupling LAMB1 to Wnt activation unidentified
    • Single-lab study
12. 2025 Medium

    Linked LAMB1 to tumor metabolism, showing it drives NF-κB-dependent HK2 upregulation and glycolysis to support glioma growth and reduce TMZ sensitivity.

    Evidence Overexpression/knockdown, Seahorse ECAR, NF-κB inhibitor, and subcutaneous tumor model

    PMID:39920513

    Open questions at the time

    • Mechanism by which LAMB1 activates NF-κB unknown
    • Single-lab study
13. 2026 Medium

    Extended LAMB1 signaling to bone-muscle crosstalk, showing recombinant LAMB1 promotes osteoclastogenesis via p38/JNK MAPK activation.

    Evidence In vitro osteoclastogenesis with recombinant LAMB1, TRAP staining, MAPK Western blotting, dual-tissue transcriptomics in an OVX model

    PMID:41690031

    Open questions at the time

    • Osteoclast receptor for LAMB1 not identified
    • Limited mechanistic detail beyond MAPK readout
14. 2026 Medium

    Implicated LAMB1 in trophoblast function, showing silencing modulates the COL3A1/RAC1 axis to enhance invasion and improve outcomes in a subchorionic hematoma model.

    Evidence siRNA and in vivo knockdown, proteomic/transcriptomic analysis, SCH rat model, trophoblast functional assays

    PMID:41840580

    Open questions at the time

    • Direct molecular link between LAMB1 and COL3A1/RAC1 not established
    • Single-lab study

• How LAMB1's matrix structural role integrates with its diverse intracellular signaling outputs (FAK/MEK, Rac1, Wnt, NF-κB, MAPK) through specific receptors across tissues remains unresolved.
• A unifying receptor logic for distinct downstream pathways is undefined
• Structural model of LAMB1 within assembled laminin and basement membrane is lacking